Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $19.37 $25.53 Friday, 10th May 2024 NTLA stock ended at $24.46. This is 1.61% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 4.85% from a day low at $24.25 to a day high of $25.42.
90 days $19.37 $34.87
52 weeks $19.37 $47.48

Historical Intellia Therapeutics Inc prices

Date Open High Low Close Volume
Oct 05, 2023 $28.73 $30.73 $28.58 $30.51 936 690
Oct 04, 2023 $29.81 $29.85 $28.29 $28.94 998 338
Oct 03, 2023 $29.38 $29.96 $28.78 $29.68 1 147 037
Oct 02, 2023 $31.50 $31.56 $29.24 $29.41 1 182 346
Sep 29, 2023 $32.22 $32.42 $31.40 $31.62 721 923
Sep 28, 2023 $32.00 $32.34 $31.13 $31.76 740 021
Sep 27, 2023 $32.49 $32.91 $31.50 $32.09 912 733
Sep 26, 2023 $32.19 $33.35 $32.17 $32.35 700 191
Sep 25, 2023 $32.13 $32.77 $31.66 $32.21 776 989
Sep 22, 2023 $33.80 $34.00 $32.37 $32.39 802 895
Sep 21, 2023 $33.34 $33.80 $32.64 $33.53 932 969
Sep 20, 2023 $34.68 $34.94 $33.88 $33.99 800 575
Sep 19, 2023 $34.87 $34.90 $33.83 $34.37 874 134
Sep 18, 2023 $35.65 $35.88 $34.96 $35.02 717 642
Sep 15, 2023 $36.06 $36.17 $35.54 $35.82 1 234 178
Sep 14, 2023 $35.80 $36.23 $35.58 $36.01 744 837
Sep 13, 2023 $37.06 $37.16 $35.36 $35.50 1 311 408
Sep 12, 2023 $38.25 $38.68 $37.11 $37.15 681 345
Sep 11, 2023 $38.03 $38.35 $37.53 $38.25 603 777
Sep 08, 2023 $37.87 $37.98 $37.02 $37.87 400 413
Sep 07, 2023 $37.47 $38.10 $36.67 $37.69 509 387
Sep 06, 2023 $37.99 $38.67 $37.65 $38.19 456 054
Sep 05, 2023 $37.30 $38.30 $36.90 $37.97 878 284
Sep 01, 2023 $37.99 $38.49 $37.56 $37.69 602 143
Aug 31, 2023 $38.07 $38.20 $37.32 $37.48 654 478
Click to get the best stock tips daily for free!

About Intellia Therapeutics Inc

Intellia Therapeutics Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemophilia A and hemophilia B, hyperoxaluria Type 1, and alpha-1 antitrypsin deficiency. Its ex vivo pipeline... NTLA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT